We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AptarGroup
ATR
$8.5B
| $95.2M | 0.18% |
608,290
-148,062
| -20% | -$22.4M |
|
152
Viking Holdings
VIK
$40.2B
| $93.7M | 0.18% |
1,759,101
+74,601
| +4% | +$3.29M |
|
153
Eagle Materials
EXP
$6.08B
| $93.2M | 0.18% |
460,921
-123,176
| -21% | -$26.5M |
|
154
Sportradar
SRAD
$3.76B
| $92.5M | 0.17% |
3,295,265
-277,462
| -8% | -$6.59M |
|
|
SARO
155
StandardAero Inc
SARO
$8.27B
| $90.6M | 0.17% |
2,863,983
+60,500
| +2% | +$1.7M |
|
156
Arista Networks
ANET
$255B
| $89.8M | 0.17% |
877,719
-708,681
| -45% | -$61.3M |
|
157
Arch Capital
ACGL
$33.7B
| $88.9M | 0.17% |
976,929
-52,047
| -5% | -$4.8M |
|
158
Expedia Group
EXPE
$38.7B
| $87.5M | 0.16% |
518,858
+126,127
| +32% | +$20.5M |
|
159
Coinbase
COIN
$50.5B
| $87M | 0.16% |
248,197
+54,976
| +28% | +$12.9M |
|
160
Williams Companies
WMB
$90.7B
| $86.7M | 0.16% |
1,380,115
+167,673
| +14% | +$9.9M |
|
161
Vertex Pharmaceuticals
VRTX
$139B
| $86.4M | 0.16% |
193,959
+23,726
| +14% | +$10.9M |
|
162
General Mills
GIS
$21.6B
| $83.9M | 0.16% |
1,619,943
+99,494
| +7% | +$5.49M |
|
163
Howmet Aerospace
HWM
$106B
| $83M | 0.16% |
445,908
+171,857
| +63% | +$26.4M |
|
164
Elastic
ESTC
$8.85B
| $83M | 0.16% |
983,732
+99,332
| +11% | +$8.4M |
|
165
Verisk Analytics
VRSK
$24.8B
| $82.7M | 0.16% |
265,579
+97,275
| +58% | +$29.5M |
|
166
Chubb
CB
$131B
| $81.7M | 0.15% |
282,119
+2,591
| +0.9% | +$746K |
|
167
Motorola Solutions
MSI
$80.8B
| $81.6M | 0.15% |
193,997
+57,587
| +42% | +$24.1M |
|
168
Tesla
TSLA
$1.39T
| $81.1M | 0.15% |
255,417
-65,293
| -20% | -$19.7M |
|
169
Sprouts Farmers Market
SFM
$7.74B
| $80.5M | 0.15% |
489,243
+92,518
| +23% | +$15.1M |
|
170
Snowflake
SNOW
$115B
| $80.5M | 0.15% |
359,626
+99,412
| +38% | +$18M |
|
|
MRUS
171
DELISTED
Merus
MRUS
| $80.4M | 0.15% |
1,528,587
+483,962
| +46% | +$22.8M |
|
172
Moderna
MRNA
$56.1B
| $79.2M | 0.15% |
2,869,271
+2,251,497
| +364% | +$59.3M |
|
173
Apollo Global Management
APO
$79.4B
| $77.4M | 0.15% |
545,789
-41,660
| -7% | -$5.52M |
|
|
P
174
Everpure Inc
P
$33B
| $77.4M | 0.15% |
1,343,658
+1,262,758
| +1,561% | +$62.8M |
|
175
Illumina
ILMN
$34.7B
| $76.6M | 0.14% |
802,343
-4,416
| -0.5% | -$358K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.